Evidence map›Paper›PMID 19794966›Full record

ArticleNeoplasia (New York, N.Y.)2009

A gene expression classifier of node-positive colorectal cancer.

Paul F Meeh, Christopher L Farrell, Randal Croshaw, Hampton Crimm, Samantha K Miller, Dora Oroian, Sangeeta Kowli, Jinyu Zhu, Wayne Carver, Wensong Wu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Increased Expression ofJournal of personalized medicine · 2021
    Article
  4. Article
  5. Review
  6. p27Oncogene · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The interconnectedness of cancer cell signaling.Neoplasia (New York, N.Y.) · 2011
    Article
  17. Article
  18. The War on Cancer rages on.Neoplasia (New York, N.Y.) · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Paul F MeehDepartment of Pathology, Microbiology and Immunology, University of South Carolina, Columbia, SC 29208, USA.
Christopher L Farrell
Randal Croshaw
Hampton Crimm
Samantha K Miller
Dora Oroian
Sangeeta Kowli
Jinyu Zhu
Wayne Carver
Wensong Wu
Edsel Pena
Phillip J Buckhaults
University of South Carolina · US

Funding

TISSUE BIOREPOSITORYP20RR017698 · NCRR · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FAYAD, RAJA · 2002 to 2011
$22.5M
Molecular Predictors of Colorectal Cancer RecurrenceR21CA127683 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BUCKHAULTS, PHILLIP JOE · 2009 to 2010
$353k
NCI NIH HHS 1R21CA127683NCI NIH HHS R21 CA127683NCRR NIH HHS P20 RR017698NCRR NIH HHS P20 RR17698
6 · The paper itself

Abstract

We used digital long serial analysis of gene expression to discover gene expression differences between node-negative and node-positive colorectal tumors and developed a multigene classifier able to discriminate between these two tumor types. We prepared and sequenced long serial analysis of gene expression libraries from one node-negative and one node-positive colorectal tumor, sequenced to a depth of 26,060 unique tags, and identified 262 tags significantly differentially expressed between these two tumors (P < 2 x 10(-6)). We confirmed the tag-to-gene assignments and differential expression of 31 genes by quantitative real-time polymerase chain reaction, 12 of which were elevated in the node-positive tumor. We analyzed the expression levels of these 12 upregulated genes in a validation panel of 23 additional tumors and developed an optimized seven-gene logistic regression classifier. The classifier discriminated between node-negative and node-positive tumors with 86% sensitivity and 80% specificity. Receiver operating characteristic analysis of the classifier revealed an area under the curve of 0.86. Experimental manipulation of the function of one classification gene, Fibronectin, caused profound effects on invasion and migration of colorectal cancer cells in vitro. These results suggest that the development of node-positive colorectal cancer occurs in part through elevated epithelial FN1 expression and suggest novel strategies for the diagnosis and treatment of advanced disease.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticBlotting, WesternCell Line, TumorCell MovementColorectal NeoplasmsFibronectinsHumansLymphatic MetastasisLymph NodesOligopeptidesReverse Transcriptase Polymerase Chain ReactionFibronectinsOligopeptides

Identifiers

PMID19794966
PMCPMC2745673
OpenAlexW1720221971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.